Thrombocytosis as a prognostic marker in stage III and IV serous ovarian cancer

OBJECTIVE: Thrombocytosis is an adverse prognostic factor in many types of cancer. We investigated if pre-treatment increased platelet counts provide prognostic information specifically in patients with stage III and IV serous ovarian cancer which is the most common clinical presentation of ovarian...

Descripción completa

Detalles Bibliográficos
Autores principales: Digklia, Antonia, Voutsadakis, Ioannis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology; Korean Urogynecologic Society 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245338/
https://www.ncbi.nlm.nih.gov/pubmed/25469333
http://dx.doi.org/10.5468/ogs.2014.57.6.457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245338/
https://www.ncbi.nlm.nih.gov/pubmed/25469333
http://dx.doi.org/10.5468/ogs.2014.57.6.457

Ejemplares similares